A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis
Crossref DOI link: https://doi.org/10.1007/s12185-015-1746-8
Published Online: 2015-02-01
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Oritani, Kenji
Okamoto, Shinichiro
Tauchi, Tetsuzo
Saito, Shigeki
Ohishi, Kohshi
Handa, Hiroshi
Takenaka, Katsuto
Gopalakrishna, Prashanth
Amagasaki, Taro
Ito, Kazuo
Akashi, Koichi
Text and Data Mining valid from 2015-02-01